Liquid biopsies were – unsurprisingly – a hot topic for discussion at the 2017 American Society of Clinical Oncology (ASCO) annual meeting, held in Chicago from June 2-5. A proper smorgasbord of ...

As head of the Prostate Cancer Foundation (PCF), oncologist Jonathan Simons can speak at length about the various challenges and inequities he encounters in his field. There’s suboptimal patient ...

When combined with the IDO1 inhibitor epacadostat, Keytruda (pembrolizumab), a PD-1 inhibitor, resulted in an overall response rate (ORR) of 35 percent in patients with advanced urothelial carcinoma, ...

Attend a virtual open house on Thursday, June 8 from 12:30 – 1 p.m. ET to learn more about the Online MS in Regulatory Science program at the University of Maryland School of Pharmacy. The program ...

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family ...